Omega Healthcare Investors (NYSE:OHI) Releases FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.840-2.860 for the period, compared to the consensus estimate of 2.830. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on OHI. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a report on Thursday. Scotiabank increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. BMO Capital Markets increased their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Finally, Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their price objective for the company from $34.00 to $35.00 in a research report on Thursday, July 25th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $39.70.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock traded down $1.27 on Friday, reaching $41.20. The stock had a trading volume of 1,901,157 shares, compared to its average volume of 1,648,304. The business’s 50 day moving average is $40.47 and its two-hundred day moving average is $35.96. The company has a market cap of $10.62 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors has a 1 year low of $27.53 and a 1 year high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a return on equity of 9.19% and a net margin of 34.41%. The firm’s revenue for the quarter was up 17.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.74 EPS. As a group, research analysts anticipate that Omega Healthcare Investors will post 2.69 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.50%. The ex-dividend date is Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.